Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo
Authors
Keywords
-
Journal
Advanced Healthcare Materials
Volume 5, Issue 19, Pages 2517-2527
Publisher
Wiley
Online
2016-08-16
DOI
10.1002/adhm.201600345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Co-delivery of Doxorubicin and PSC 833 (Valspodar) by Stealth Nanoliposomes for Efficient Overcoming of Multidrug Resistance
- (2016) Elmira Bajelan et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Acid-responsive PEGylated doxorubicin prodrug nanoparticles for neuropilin-1 receptor-mediated targeted drug delivery
- (2015) Huijuan Song et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Preparation of a multifunctional verapamil-loaded nano-carrier based on a self-assembling PEGylated prodrug
- (2015) Dongping Zhao et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics
- (2015) Sophie Marchal et al. DRUGS
- Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice
- (2015) Dai Hai Nguyen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Enhancing cancer targeting and anticancer activity by a stimulus-sensitive multifunctional polymer-drug conjugate
- (2015) Ying Tu et al. JOURNAL OF CONTROLLED RELEASE
- Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery
- (2015) Minghui Xu et al. Materials Science & Engineering C-Materials for Biological Applications
- Liposome promotion of tumor growth is associated with angiogenesis and inhibition of antitumor immune responses
- (2015) Manoj K. Sabnani et al. Nanomedicine-Nanotechnology Biology and Medicine
- Preclinical Evaluation of Antitumor Activity of Acid-Sensitive PEGylated Doxorubicin
- (2014) Diankui Sun et al. ACS Applied Materials & Interfaces
- Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin
- (2014) Lipeng Qiu et al. BIOMATERIALS
- Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR
- (2014) Jie Shen et al. BIOMATERIALS
- Cisplatin-loaded polymer/magnetite composite nanoparticles as multifunctional therapeutic nanomedicine
- (2014) Yan Zhang et al. CHINESE JOURNAL OF POLYMER SCIENCE
- Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery
- (2014) Gozde Unsoy et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
- (2014) Charlene M. Dawidczyk et al. JOURNAL OF CONTROLLED RELEASE
- Doxorubicin Nanoconjugates
- (2014) Kannan Deepa et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- MicroRNAs as regulators of drug transporters, drug-metabolizing enzymes, and tight junctions: Implication for intestinal barrier function
- (2014) Kenji Ikemura et al. PHARMACOLOGY & THERAPEUTICS
- Nanotechnology and drug resistance
- (2013) Tamara Minko ADVANCED DRUG DELIVERY REVIEWS
- Multidrug resistance: Physiological principles and nanomedical solutions
- (2013) Sijumon Kunjachan et al. ADVANCED DRUG DELIVERY REVIEWS
- Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
- (2013) Qi Yin et al. ADVANCED DRUG DELIVERY REVIEWS
- Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition
- (2013) Un-Jung Yun et al. BIOCHEMICAL PHARMACOLOGY
- The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines
- (2013) Wei-Wu Chen et al. BREAST
- Combating P-glycoprotein-Mediated Multidrug Resistance Using Therapeutic Nanoparticles
- (2013) Qiu Zhang et al. CURRENT PHARMACEUTICAL DESIGN
- The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance
- (2013) Wan et al. International Journal of Nanomedicine
- Reversal of Multidrug Resistance by Mitochondrial Targeted Self-Assembled Nanocarrier Based on Stearylamine
- (2013) Zhiwen Zhang et al. MOLECULAR PHARMACEUTICS
- Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review
- (2013) Ping Ma et al. Nano Today
- The role of endosome evasion bypass in the reversal of multidrug resistance by lipid/nanoparticle assemblies
- (2013) Zhen Li et al. Journal of Materials Chemistry B
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells
- (2012) Xinxin Zhang et al. BIOMATERIALS
- Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
- (2012) Man Yu et al. CANCER AND METASTASIS REVIEWS
- Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts
- (2012) Preethy Prasad et al. CANCER LETTERS
- The Role of Estrogen and Estrogen Receptors in Chemoresistance
- (2012) M. Sui et al. CURRENT MEDICINAL CHEMISTRY
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: In vitro and in vivo studies
- (2012) Hongfang Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Self-assembled nanoparticles from folate-decorated maleilated pullulan-doxorubicin conjugate for improved drug delivery to cancer cells
- (2012) Fei Li et al. POLYMER INTERNATIONAL
- Self-assembling doxorubicinprodrug forming nanoparticles for cancer chemotherapy: synthesis and anticancer study in vitro and in vivo
- (2012) Pengfei Gou et al. Journal of Materials Chemistry B
- Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin
- (2011) Xiao-Bing Xiong et al. ACS Nano
- Use of Size and a Copolymer Design Feature To Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model
- (2011) Huan Meng et al. ACS Nano
- Redox-Responsive Nanoparticles from the Single Disulfide Bond-Bridged Block Copolymer as Drug Carriers for Overcoming Multidrug Resistance in Cancer Cells
- (2011) Yu-Cai Wang et al. BIOCONJUGATE CHEMISTRY
- Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance
- (2011) Xiufeng Ji et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro
- (2011) Forrest M. Kievit et al. JOURNAL OF CONTROLLED RELEASE
- Nuclear drug delivery for cancer chemotherapy
- (2011) Meihua Sui et al. JOURNAL OF CONTROLLED RELEASE
- Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism
- (2011) Jianan Shen et al. Nanoscale
- Poly(l-lactide)-Vitamin E TPGS Nanoparticles Enhanced the Cytotoxicity of Doxorubicin in Drug-Resistant MCF-7 Breast Cancer Cells
- (2010) Po-Yu Li et al. BIOMACROMOLECULES
- Endocytosis of nanomedicines
- (2010) Gaurav Sahay et al. JOURNAL OF CONTROLLED RELEASE
- Prodrugs Forming High Drug Loading Multifunctional Nanocapsules for Intracellular Cancer Drug Delivery
- (2010) Youqing Shen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers:in vitroandin vivoeffects
- (2010) Huadong Tang et al. Nanomedicine
- Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma
- (2010) Michiro Susa et al. PLoS One
- Clinical experience with anthracycline antibiotics–HPMA copolymer–human immunoglobulin conjugates
- (2009) Blanka Rihova ADVANCED DRUG DELIVERY REVIEWS
- ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
- (2009) Paul D. W. Eckford et al. CHEMICAL REVIEWS
- Multi-functional nanocarriers to overcome tumor drug resistance
- (2008) Lara S. Jabr-Milane et al. CANCER TREATMENT REVIEWS
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Carbonyl Reductase 1 Is a Predominant Doxorubicin Reductase in the Human Liver
- (2008) N. Kassner et al. DRUG METABOLISM AND DISPOSITION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started